title: Melatonin inhibits alcohol-induced increases in duodenal mucosal permeability in rats in vivo.
abstract: Increased intestinal permeability is often associated with epithelial inflammation, leaky gut, or other pathological conditions in the gastrointestinal tract. We recently found that melatonin decreases basal duodenal mucosal permeability, suggesting a mucosal protective mode of action of this agent. The aim of the present study was to elucidate the effects of melatonin on ethanol-, wine-, and HCl-induced changes of duodenal mucosal paracellular permeability and motility. Rats were anesthetized with thiobarbiturate and a ~30-mm segment of the proximal duodenum was perfused in situ. Effects on duodenal mucosal paracellular permeability, assessed by measuring the blood-to-lumen clearance of ⁵¹Cr-EDTA, motility, and morphology, were investigated. Perfusing the duodenal segment with ethanol (10 or 15% alcohol by volume), red wine, or HCl (25-100 mM) induced concentration-dependent increases in paracellular permeability. Luminal ethanol and wine increased, whereas HCl transiently decreased duodenal motility. Administration of melatonin significantly reduced ethanol- and wine-induced increases in permeability by a mechanism abolished by the nicotinic receptor antagonists hexamethonium (iv) or mecamylamine (luminally). Signs of mucosal injury (edema and beginning of desquamation of the epithelium) in response to ethanol exposure were seen only in a few villi, an effect that was histologically not changed by melatonin. Melatonin did not affect HCl-induced increases in mucosal permeability or decreases in motility. Our results show that melatonin reduces ethanol- and wine-induced increases in duodenal paracellular permeability partly via an enteric inhibitory nicotinic-receptor dependent neural pathway. In addition, melatonin inhibits ethanol-induced increases in duodenal motor activity. These results suggest that melatonin may serve important gastrointestinal barrier functions.
authors: Division of Physiology, Department of Neuroscience, Uppsala University, Uppsala, Sweden.
authors: Anna
authors: A
authors: Sommansson
authors: Wan Salman Wan
authors: WS
authors: Saudi
authors: Olof
authors: O
authors: Nylander
authors: Markus
authors: M
authors: Sjöblom
mesh_terms: D000818:Animals; D004386:Duodenum / Q000187:drug effects*; D000431:Ethanol / Q000494:pharmacology*; D018738:Hexamethonium / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000187:drug effects*; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D008550:Melatonin / Q000494:pharmacology*; D018733:Nicotinic Antagonists / Q000494:pharmacology; D010539:Permeability / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D044094:Receptors, Melatonin / Q000037:antagonists & inhibitors; D014363:Tryptamines / Q000494:pharmacology; D014920:Wine
chemical_list: D018733:Nicotinic Antagonists; D044094:Receptors, Melatonin; D014363:Tryptamines; C057154:luzindole; D018738:Hexamethonium; D000431:Ethanol; D008464:Mecamylamine; D008550:Melatonin
keywords: alcoholic liver disease; duodenal barrier; duodenal bicarbonate secretion; intestinal barrier dysfunction; leaky gut syndrome